The Michael J . Fox Foundation
Annual Letter from the CEO and the Co-Founder
Todd Sherer , PhD , ( right ) with David Standaert , MD , PhD , at the annual PD Therapeutics Conference
Debi Brooks with Michael J . Fox at an MJFF salon sharing research progress
Dear Friend ,
Understanding Parkinson ’ s disease is the starting point of every effort to accelerate the cure . Years of work spent uncovering Parkinson ’ s secrets — defining the highly variable patient experience , shedding light on genetic origins of disease , mapping molecular pathways — are now paying off in a tangibly quickening tempo of progress . Researchers are increasingly linking pathology to clinical symptoms ( and vice versa ) to inform therapeutic target and biomarker identification .
4